Severe retinopathy of prematurity is associated with early post-natal low platelet count.
Anemia
/ complications
Biomarkers
/ blood
Blood Platelets
/ metabolism
Disease Progression
Female
Gestational Age
Humans
Infant
Infant, Newborn
Infant, Premature
Infant, Very Low Birth Weight
Inflammation
/ physiopathology
Male
Platelet Count
/ methods
Retinopathy of Prematurity
/ physiopathology
Retrospective Studies
Thrombocytopenia
/ complications
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
13 01 2021
13 01 2021
Historique:
received:
21
07
2020
accepted:
18
11
2020
entrez:
14
1
2021
pubmed:
15
1
2021
medline:
18
8
2021
Statut:
epublish
Résumé
Pathophysiology of retinopathy of prematurity (ROP) still presents a gap. Lately blood tests parameters of premature infants have been measured at different times of ROP, attempting to detect correlations with ROP development and progression. So far, very early post-natal biomarkers, predictive of ROP outcome, have not been detected. Our purpose is to evaluate, in the earliest post birth blood sample, the correlation between routinely dosed blood parameters and ROP outcome. 563 preterm babies, screened according to ROP guidelines, were included and classified in conformity with ET-ROP study in "Group 1" (ROP needing treatment), "Group 2" (ROP spontaneously regressed) and "noROP" group (never developed ROP). The earliest (within an hour after delivery) blood test parameters routinely dosed in each preterm infant were collected. Platelet count was decreased in Group 1 versus noROP group (p = 0.0416) and in Group 2 versus noROP group (p = 0.1093). The difference of thrombocytopenic infants among groups was statistically significant (p = 0.0071). CRP was higher in noROP versus all ROPs (p = 0.0331). First post-natal blood sample revealed a significant thrombocytopenia in ROP needing treatment, suggesting a role of platelets in the pathophysiology and progression of ROP, possibly considering it as a predictive parameter of ROP evolution.
Identifiants
pubmed: 33441659
doi: 10.1038/s41598-020-79535-0
pii: 10.1038/s41598-020-79535-0
pmc: PMC7807000
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
891Références
Pediatrics. 2015 Aug;136(2):e361-70
pubmed: 26216323
Retina. 2019 Apr;39(4):706-711
pubmed: 29370028
Wien Med Wochenschr. 2019 Mar;169(3-4):87-92
pubmed: 30084094
BMJ Open. 2017 Mar 21;7(3):e013366
pubmed: 28325857
Semin Perinatol. 2019 Oct;43(6):317-322
pubmed: 31151778
Platelets. 2018 Jan;29(1):65-70
pubmed: 28374642
Pediatrics. 2019 Mar;143(3):
pubmed: 30824604
Arch Ophthalmol. 2005 Jul;123(7):991-9
pubmed: 16009843
Trans Am Ophthalmol Soc. 2005;103:225-34; discussion 234-6
pubmed: 17057805
Retina. 2010 Apr;30(4 Suppl):S20-3
pubmed: 20224477
Ophthalmol Retina. 2018 Sep;2(9):949-962
pubmed: 30250936
Exp Eye Res. 2019 Oct;187:107743
pubmed: 31348907
Blood. 2008 Feb 1;111(3):1227-33
pubmed: 17962514
J AAPOS. 2011 Feb 1;15(1):e3-e4
pubmed: 22025899
Pediatr Res. 2019 Aug;86(2):276-282
pubmed: 30297879
J AAPOS. 2018 Apr;22(2):119-123
pubmed: 29548837
Arch Ophthalmol. 2003 Dec;121(12):1684-94
pubmed: 14662586
J AAPOS. 2015 Aug;19(4):327-31
pubmed: 26239207
Chin Med J (Engl). 2010 Oct;123(20):2929-37
pubmed: 21034609
Transfus Med Rev. 2016 Oct;30(4):183-8
pubmed: 27282660
Heart Lung Circ. 2018 Apr;27(4):489-496
pubmed: 28579228
Arch Dis Child. 2017 Sep;102(9):853-857
pubmed: 28465303
Arch Dis Child Fetal Neonatal Ed. 2020 May;105(3):270-278
pubmed: 31326921
JCI Insight. 2018 Oct 4;3(19):
pubmed: 30282834
JCI Insight. 2019 Jul 25;4(14):
pubmed: 31341109
Nat Rev Drug Discov. 2007 Apr;6(4):273-86
pubmed: 17396134
PLoS One. 2019 Jul 18;14(7):e0219934
pubmed: 31318921
Neonatology. 2017;111(1):79-85
pubmed: 27631399
Surv Ophthalmol. 2018 Sep - Oct;63(5):618-637
pubmed: 29679617
Medicine (Baltimore). 2017 May;96(21):e6981
pubmed: 28538403